Moneycontrol
Get App
SENSEX NIFTY
you are here:

Natural Capsules Ltd.

BSE Live

Feb 26, 16:00
49.30 -1.60 (-3.14%)
Volume
AVERAGE VOLUME
5-Day
563
10-Day
547
30-Day
694
837
  • Prev. Close

    50.90

  • Open Price

    53.10

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

(%)
Volume
No Data Available
  • Prev. Close

  • Open Price

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

Natural Capsules is not listed on NSE

ANNOUNCEMENTS ON Natural Capsule

  • Feb 08, 2020 18:07 Source: BSE

    Natural Capsules - Results - Financial Results For The Quarter Ended 31.12.2019

    Board of Directors at their meeting held on 08.02.2020, inter alia has transacted the following: Unaudited Standalone Financial Results & Unaudited Consolidated Financial Results for the quarter ended 31st December, 2019, along with Limited Review Report issued by the Statutory Auditors. The Board Meeting commenced at 4.00 PM and concluded at 6.00 PM. Kindly take the above information on records.

  • Feb 08, 2020 18:02 Source: BSE

    Natural Capsules - Outcome Of Board Meeting Held On 08Th February 2020 Pursuant To Regulation 30, 33(1)(D) Of SEBI(Listing Obligations & Disclosure Requirements) Regulations, 2015:

    Board of Directors at their meeting held on 08.02.2020, inter alia has transacted the following: Unaudited Standalone Financial Results & Unaudited Consolidated Financial Results for the quarter ended 31st December, 2019, along with Limited Review Report issued by the Statutory Auditors. The Board Meeting commenced at 4.00 PM and concluded at 6.00 PM. Kindly take the above information on records.

  • Jan 28, 2020 16:24 Source: BSE

    Natural Capsules - Board Meeting Intimation for To Consider And Approve Unaudited Standalone Financial And Unaudited Consolidated Financial Results Of The Company For The Quarter Ended December 31St 2019

    NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2020 ,inter alia, to consider and approve Sub: Board Meeting We wish to inform you that 132nd meeting of the Board of Directors of the company is scheduled to be held on Saturday, 08th Feb, 2020, inter alia to consider the following: 1. To consider and approve unaudited standalone financial and unaudited consolidated financial results of the Company for the Quarter ended December 31st 2019. Pursuant to and in compliance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the policy / code of internal procedures and conduct for regulating, monitoring and reporting of trading by insiders of the Company, the trading window for directors and specified employees is already closed and it shall remain closed till the conclusion of 48 hours after the declaration of financial results of the Company.

  • Jan 17, 2020 19:18 Source: BSE

    Natural Capsules - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has now received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Sangeetha

  • Jan 10, 2020 16:37 Source: BSE

    Natural Capsules - Statement Of Investor Complaints For The Quarter Ended December 2019 (Revised)

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0000
    Name of the Signatory :- SUNIL L MUNDRA
    Designation :- Director

  • Jan 10, 2020 16:33 Source: BSE

    Natural Capsules - Statement Of Investor Complaints For The Quarter Ended December 2019

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0000
    Name of the Signatory :- SUNIL L MUNDRA
    Designation :- Authorised Signatory

  • Jan 10, 2020 15:28 Source: BSE

    Natural Capsules - Shareholding for the Period Ended December 31, 2019

    Natural Capsules Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here

  • Jan 02, 2020 17:50 Source: BSE

    Natural Capsules - Closure of Trading Window

    Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices, we wish to inform that the "Trading Window" for dealing in the equity shares of the Company shall remain closed for all Designated Person and their immediate relatives with immediate effect till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter ended 31st December 2019.

  • Dec 21, 2019 19:01 Source: BSE

    Natural Capsules - Announcement under Regulation 30 (LODR)-Acquisition

    Outcome of Board Meeting held on 21st December, 2019 pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015: In accordance with Regulation 30, read with Schedule III, Part A, Para B, Clause 2 & 5 of SEBI (Listing Obligations & Disclosure Requirements)Regulations, 2015 and Annexure 1 of SEBI circular CIR/CFD/CMD/4/2015 dated September, 9 2015, we wish to inform you that the Board of Directors at their meeting held today i.e. 21.12.2019, have approved Company''s proposal to acquire new business. Natural capsules to acquire API business of Naari Pharma Private Limited Strategic Rationale for Diversification:

  • Dec 09, 2019 12:31 Source: BSE

    Natural Capsules - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 this is to inform the exchange that the following Share certificates (s) of the Company has been reported lost/misplaced and the share holder of such lost share certificate has requested the Company through our RTA, for issue of Duplicate Share Certificates(s): Sr. No. Name of the Shareholder(s) Folio No. Share Certificate No. No. of Share Distinctive No. (From) Distinctive No. (to) Date of receipt of information 1 Himanshu V Parekh 00004628 28335 100 2833401 2833500 07.12.2019 28336 100 2833501 2833600 28337 100 2833601 2833700 28338 100 2833701 2833800 The Company is in process to issue the duplicate share certificates to the shareholders after completion of required formalities. Kindly take the same on your records.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Feb 08, 2020
Remark : Quarterly Results